Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MRNA | NASDAQ | USD | Real-time | |
MRNA | Mexico | MXN | Delayed | |
MRNA | Milan | EUR | Real-time | |
0QF | TradeGate | EUR | Delayed | |
0QF | Frankfurt | EUR | Delayed | |
MRNA | Vienna | EUR | Real-time | |
MRNA_KZ | KASE | USD | Delayed | |
MRNA_KZTQKD | KASE | USD | Delayed | |
MRNA | Lima | USD | Delayed |
* Eurozone banks come off 14-month high * Food and beverage sector top performer in Europe * BoE starts tapering bond purchases, FTSE at over 14-monthhigh (Updates to market close)...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Sell | Sell | Sell | Sell | Buy |
Technical Indicators | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Neutral |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Abandoned Baby Bullish | 15 | Current | |||
Morning Doji Star | 15 | Current | |||
Morning Star | 15 | Current | |||
Belt Hold Bullish | 30 | Current | |||
Bullish Engulfing | 30 | Current | |||
Belt Hold Bullish | 1H | Current | |||
Bullish Engulfing | 1H | Current | |||
Completed Patterns | |||||
Bullish Engulfing | 1W | 1 | Apr 07, 2024 | ||
Bullish doji Star | 15 | 1 | Apr 19, 2024 17:45 | ||
Upside Gap Three Methods | 1M | 2 | Feb 24 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NASDAQ | 101.41 | 0.00 | 0.00 | 2,514,546 | -0.58% | USD | |||
Mexico | 1,750.00 | 1,719.00 | 1,928.00 | 0 | 0.00% | MXN | |||
Milan | 95.87 | 0.00 | 0.00 | 536 | -0.18% | EUR | |||
TradeGate | 94.40 | 94.90 | 95.48 | 2,745 | -2.24% | EUR | |||
Frankfurt | 96.2200 | 95.0000 | 95.4200 | 180 | -0.30% | EUR | |||
Vienna | 95.88 | 95.04 | 96.25 | 0 | 0.00% | EUR | |||
KASE | 71.00 | 0.00 | 0.00 | 0 | 0.00% | USD | |||
KASE | 0.00% | USD | |||||||
Lima | 108.90 | 0.00 | 0.00 | 44 | +2.25% | USD |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
DMCI | 10.080 | 10.360 | 10.040 | -0.640 | -5.97% | 7.20M | 19/04 | ||
LT Group | 9.570 | 9.650 | 9.430 | -0.030 | -0.31% | 2.43M | 19/04 | ||
AREIT, | 33.45 | 34.35 | 33.00 | -0.75 | -2.19% | 634.00K | 19/04 | ||
Bank of the Philippine Islands | 124.00 | 124.00 | 119.10 | 0.00 | 0.00% | 1.94M | 19/04 | ||
Semirara Mining | 30.00 | 31.00 | 29.85 | -1.00 | -3.23% | 1.55M | 19/04 | ||
Ayala Land | 27.000 | 27.800 | 27.000 | -0.950 | -3.40% | 16.36M | 19/04 | ||
Bright Kindle | 1.360 | 1.540 | 1.250 | -0.140 | -9.33% | 4.43M | 19/04 | ||
Converge Information Communications Technology Sol | 8.56 | 9.15 | 8.50 | -0.53 | -5.83% | 3.48M | 19/04 | ||
Universal Robina | 90.00 | 95.50 | 90.00 | -3.00 | -3.23% | 1.96M | 19/04 | ||
PLDT | 1,300.00 | 1,314.00 | 1,290.00 | 0.00 | 0.00% | 43.87K | 19/04 |
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review